TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10595875

Group type: EXPERIMENTAL
Intervention: Large-diameter suction system (5/8‐inch open‐bore suction tip and 3/4‐inch tubing attached to a 1‐inch pour spout)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard suction systems (small-diameter blunt‐nosed and medium-diameter open‐bore 1/4‐inch suction tips connected to 1/4‐inch tubing)
Number of subjects: 0
Study: 8942410

Group type: EXPERIMENTAL
Intervention: Aged garlic extract (7.2 g per day)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 1916166

Group type: EXPERIMENTAL
Intervention: Per-rectal pulsed irrigation
Number of subjects: 34

Group type: COMPARATOR
Intervention: Per-oral colonic lavage
Number of subjects: 34
Study: 6345426

Group type: EXPERIMENTAL
Intervention: Conalbumin plus traditional dietetic therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional dietetic therapy
Number of subjects: 40
Study: 29607730

Group type: EXPERIMENTAL
Intervention: Rank-Preserving Structural Failure Time Model (RPSFTM) applied to simulated datasets with varying levels of crossover.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hazard Ratio (HR) analysis using RPSFTM.
Number of subjects: 0
Study: 25730587

Group type: EXPERIMENTAL
Intervention: HPV DNA self-sampling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pap smear
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HPV DNA self-sampling and Pap smear
Number of subjects: 0
Study: 24716847

Group type: EXPERIMENTAL
Intervention: Transdermal testosterone gel 300 mcg/day
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 23442823

Group type: EXPERIMENTAL
Intervention: JE-CV booster dose
Number of subjects: 450

Group type: COMPARATOR
Intervention: JE-CV
Number of subjects: 450
Study: 19945815

Group type: EXPERIMENTAL
Intervention: Simulated medical interview (video)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Audio-only version of the interview
Number of subjects: 100

Group type: COMPARATOR
Intervention: Transcribed version of the interview
Number of subjects: 100
Study: 18194330

Group type: EXPERIMENTAL
Intervention: Dental hygienist brushing teeth and applying Duraphat vanish to active root caries lesions once a month
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: 5000 ppm F-toothpaste used twice a day
Number of subjects: 215

Group type: COMPARATOR
Intervention: 1450 ppm F-toothpaste used twice a day
Number of subjects: 215
Study: 17663803

Group type: EXPERIMENTAL
Intervention: Dietary portfolio high in plant sterols (1 g/4200 kJ), soya proteins (21.4 g/4200 kJ), soluble fibres (9.8 g/4200 kJ) and almonds (14 g/4200 kJ)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 20 mg lovastatin
Number of subjects: 34

Group type: COMPARATOR
Intervention: Very-low saturated fat diet (control)
Number of subjects: 34
Study: 12687817

Group type: EXPERIMENTAL
Intervention: Automatic group (group A, n = 44) with Autoslope algorithm
Number of subjects: 87

Group type: COMPARATOR
Intervention: Manual group (group M, n = 43) performing a walk test and using sensor-indicated rate histograms
Number of subjects: 87

Group type: COMPARATOR
Intervention: Manual group (group M, n = 43)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Automatic group (group A, n = 44)
Number of subjects: 87
Study: 10767068

Group type: EXPERIMENTAL
Intervention: Interleaved spiral sequence
Number of subjects: 45

Group type: COMPARATOR
Intervention: Segmented k-space FLASH sequence
Number of subjects: 45
Study: 9064372

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 85

Group type: COMPARATOR
Intervention: Spironolactone
Number of subjects: 85
Study: 1524078

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil 250 mg twice daily (n = 157)
Number of subjects: 317

Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate 500 mg three times daily (n = 160)
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil 250 mg twice daily
Number of subjects: 317

Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate 500 mg three times daily
Number of subjects: 317
Study: 6406442

Group type: EXPERIMENTAL
Intervention: Bupropion (150 or 450 mg/day)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Imipramine (up to 200 mg/day)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 30059269

Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 37% carbamide peroxide
Number of subjects: 50

Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 50
Study: 29912913

Group type: EXPERIMENTAL
Intervention: Probiotic capsules containing Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 38
Study: 27294719

Group type: EXPERIMENTAL
Intervention: Multi-domain training
Number of subjects: 84

Group type: COMPARATOR
Intervention: Single-domain training (inhibition, visuomotor function, spatial navigation)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: All training groups (multi-domain and single-domain)
Number of subjects: 84
Study: 24386906

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study: 22524802

Group type: EXPERIMENTAL
Intervention: Risk factor list type health risk appraisal
Number of subjects: 60

Group type: COMPARATOR
Intervention: Risk score type health risk appraisal
Number of subjects: 60
Study: 19604187

Group type: EXPERIMENTAL
Intervention: Monitor in direct line-of-sight
Number of subjects: 31

Group type: COMPARATOR
Intervention: Monitor perpendicular to the target
Number of subjects: 31
Study: 17676423

Group type: EXPERIMENTAL
Intervention: n-3 PUFA (5.2 g daily)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Olive oil (control)
Number of subjects: 41
Study: 15207999

Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 146

Group type: COMPARATOR
Intervention: Physical Therapy
Number of subjects: 146
Study: 11593072

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 27

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 27
Study: 9673809

Group type: EXPERIMENTAL
Intervention: S-fluoxetine
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 8033434

Group type: EXPERIMENTAL
Intervention: High-dose intravenous immune globulin (IVIG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plasma exchange (PE)
Number of subjects: 0
Study: 2917360

Group type: EXPERIMENTAL
Intervention: 250 mg 4-OHA orally once, twice, and 4 times daily for 2 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 250 mg i.m. every 2 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 250 mg 4-OHA orally 4 times daily
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Parenteral treatment
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 4-OHA p.o.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 4-OHA i.m.
Number of subjects: 40
Study: 1095081

Group type: EXPERIMENTAL
Intervention: d-amphetamine
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: thioridazine
Number of subjects: 62

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 62
Study: 31103765

Group type: EXPERIMENTAL
Intervention: MRI parameter scoring system for PS
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: MRI parameter scoring system for TS
Number of subjects: 70
Study: 28050702

Group type: EXPERIMENTAL
Intervention: Isoflurane anesthesia
Number of subjects: 25
Study: 26163731

Group type: EXPERIMENTAL
Intervention: New computerized cognitive and social cognition program
Number of subjects: 53
Study: 23685080

Group type: EXPERIMENTAL
Intervention: Inner thigh Taping
Number of subjects: 191

Group type: COMPARATOR
Intervention: Traction with a 500 mL weighted bag
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Inner thigh Taping and Traction
Number of subjects: 191
Study: 21131871

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC) - four cycles of 5-min arm ischemia/5-min reperfusion
Number of subjects: 34

Group type: COMPARATOR
Intervention: Low-pressure control procedure
Number of subjects: 34
Study: 19244949

Group type: EXPERIMENTAL
Intervention: 2.2-mm incision micro-coaxial phacoemulsification
Number of subjects: 22

Group type: COMPARATOR
Intervention: 3.0-mm traditional coaxial phacoemulsification
Number of subjects: 22
Study: 17302684

Group type: EXPERIMENTAL
Intervention: Antiarrhythmic therapy (preferably amiodarone)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (ablation alone)
Number of subjects: 107
Study: 15123391

Group type: EXPERIMENTAL
Intervention: Real stimulation (rTMS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 24
Study: 11173143

Group type: EXPERIMENTAL
Intervention: Conformal radiotherapy
Number of subjects: 79

Group type: COMPARATOR
Intervention: Conventional radiotherapy
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Conformal radiotherapy with dose escalation
Number of subjects: 79
Study: 9744780

Group type: EXPERIMENTAL
Intervention: Weekly 5‐FU 600 mg/m2 i.v. bolus (30 patients)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Weekly 5‐FU 600 mg/m2 bolus plus leucovorin (LV) 500 mg/m2 2‐h i.v. infusion (28 patients)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Weekly 5‐FU 2600 mg/m2 24‐h continuous i.v. infusion plus LV 100 mg 4‐h i.v. infusion and 50 mg orally every 4 h for five doses (24 patients)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (patients < 65 years of age)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: All elderly patients
Number of subjects: 82
Study: 8059475

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 160

Group type: COMPARATOR
Intervention: Lorazepam
Number of subjects: 160
Study: 3059187

Group type: EXPERIMENTAL
Intervention: Zidovudine (AZT)
Number of subjects: 281

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 281
Study: 31714455

Group type: EXPERIMENTAL
Intervention: LC + SCBA
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: LC only
Number of subjects: 21

Group type: COMPARATOR
Intervention: PT
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Heart rate and lactate measures
Number of subjects: 21
Study: 31377776

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 962

Group type: EXPERIMENTAL
Intervention: Aspirin plus clopidogrel
Number of subjects: 962

Group type: EXPERIMENTAL
Intervention: Aspirin or transoesophageal echocardiogram prior to cardioversion
Number of subjects: 962

Group type: EXPERIMENTAL
Intervention: No oral anticoagulation or transoesophageal echocardiogram prior to cardioversion
Number of subjects: 962

Group type: EXPERIMENTAL
Intervention: Successful cardioversion
Number of subjects: 962

Group type: EXPERIMENTAL
Intervention: Unsuccessful cardioversion
Number of subjects: 962

Group type: COMPARATOR
Intervention: Aspirin or aspirin plus clopidogrel
Number of subjects: 962
Study: 28067986

Group type: EXPERIMENTAL
Intervention: Colostomy with stoma rod
Number of subjects: 151

Group type: COMPARATOR
Intervention: Colostomy without stoma rod
Number of subjects: 151
Study: 25452653

Group type: EXPERIMENTAL
Intervention: Coparenting breastfeeding support intervention
Number of subjects: 214

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 214
Study: 22938679

Group type: EXPERIMENTAL
Intervention: Team participation (three-person teams)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Individual participation
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Team participation
Number of subjects: 57
Study: 21203376

Group type: EXPERIMENTAL
Intervention: 3 EEG derivations (F4/M1, C4/M1, O2/M1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 1 EEG derivation (C4/M1)
Number of subjects: 30
Study: 18180178

Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG) monotherapy
Number of subjects: 82

Group type: COMPARATOR
Intervention: Undefined TT group
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Therapeutic Drug Monitoring (TDM)
Number of subjects: 82
Study: 16527712

Group type: EXPERIMENTAL
Intervention: Veres intraperitoneal CO2 insufflation pressure
Number of subjects: 356
Study: 14624218

Group type: EXPERIMENTAL
Intervention: Combined medical and conservative surgical approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 0
Study: 12014026

Group type: EXPERIMENTAL
Intervention: Ebastine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9596598

Group type: EXPERIMENTAL
Intervention: General practitioner safety advice plus access to low cost safety equipment for families receiving means tested state benefits
Number of subjects: 165

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 165
Study: 7865714

Group type: EXPERIMENTAL
Intervention: Brush before biopsy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Suction cytology
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Brush after biopsy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Endoscopic biopsy
Number of subjects: 40
Study: 2670728

Group type: EXPERIMENTAL
Intervention: COP regimen
Number of subjects: 63

Group type: COMPARATOR
Intervention: CHOP regimen
Number of subjects: 63
Study: 606768

Group type: EXPERIMENTAL
Intervention: Intramuscular vaccination (200 chick cell-agglutinating units/0.5-ml dose)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Intradermal vaccination (40 chick cell-agglutinating units/0.1-ml dose)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Intradermal vaccination
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Intramuscular vaccination
Number of subjects: 2
Study: 31702015

Group type: EXPERIMENTAL
Intervention: Levothyroxine (LT4)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study: 30989788

Group type: EXPERIMENTAL
Intervention: Vaginal slow‐release misoprostol (Misodel®)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Oral solution of misoprostol (Cytotec®)
Number of subjects: 196
Study: 28623755

Group type: EXPERIMENTAL
Intervention: Adjunctive lacosamide (LCM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (≥2 AEDs with stable dosing)
Number of subjects: 50
Study: 26308294

Group type: EXPERIMENTAL
Intervention: Hydrocortisone 50 mg twice daily for 1 week
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo 50 mg twice daily for 1 week
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 23459196

Group type: EXPERIMENTAL
Intervention: HIV prevention intervention package in intervention clinics
Number of subjects: 3538

Group type: COMPARATOR
Intervention: Comparison clinics (control)
Number of subjects: 3538
Study: 20878324

Group type: EXPERIMENTAL
Intervention: Intensive Insulin Therapy (IIT)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Conventional Insulin Therapy (CIT)
Number of subjects: 179
Study: 18648227

Group type: EXPERIMENTAL
Intervention: Sugammadex 16 mg/kg administered 3 min after 1.0 mg/kg rocuronium
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Sugammadex 16 mg/kg administered 15 min after 1.0 mg/kg rocuronium
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Sugammadex 16 mg/kg administered 3 min after 1.2 mg/kg rocuronium
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Sugammadex 16 mg/kg administered 15 min after 1.2 mg/kg rocuronium
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Sugammadex
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study: 17032193

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) 10,000 IU 3 x/week
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO)
Number of subjects: 40
Study: 14641261

Group type: EXPERIMENTAL
Intervention: Computer-assisted training system for simulation of pars plana vitrectomy
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (no in vitro training)
Number of subjects: 14
Study: 11098741

Group type: EXPERIMENTAL
Intervention: Non-bridging external fixation using a small A0 external fixator
Number of subjects: 40

Group type: COMPARATOR
Intervention: Percutaneous Kirschner wire fixation and plaster
Number of subjects: 40
Study: 9262298

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (LDA) 50 mg/day
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 66
Study: 8371143

Group type: EXPERIMENTAL
Intervention: Intranasal cocaine (100 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Intranasal cocaine (100 mg) with alcohol (1 g/kg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Alcohol alone (1 g/kg)
Number of subjects: 9
Study: 31003194

Group type: EXPERIMENTAL
Intervention: Intervention arm (computerized sessions focused on caregiver-adolescent communication, support, and monitoring)
Number of subjects: 181
Study: 28657937

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 280

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 280
Study: 27461846

Group type: EXPERIMENTAL
Intervention: Tedizolid phosphate 200 mg IV
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Tedizolid phosphate 200 mg PO
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Tedizolid phosphate 200 mg (multiple dosing)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Tedizolid phosphate 200 mg
Number of subjects: 16
Study: 25402495

Group type: EXPERIMENTAL
Intervention: Zirconium cyclosilicate 5 g daily for 28 days
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Zirconium cyclosilicate 10 g daily for 28 days
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Zirconium cyclosilicate 15 g daily for 28 days
Number of subjects: 258

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 258
Study: 22192101

Group type: EXPERIMENTAL
Intervention: LithoClast classic (Group 1)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Holmium Laser (Group 2)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: StoneBreaker™ (Group 3)
Number of subjects: 69
Study: 20387023

Group type: EXPERIMENTAL
Intervention: Changes in exercise self-efficacy
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Changes in health-related goal ratings
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Changes in walking goal ratings
Number of subjects: 313
Study: 18818174

Group type: EXPERIMENTAL
Intervention: 1% glucose acetated Ringer solution containing Mg2+
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glucose free solution containing Na+ 130 mEq/L without Mg2+
Number of subjects: 0
Study: 16303055

Group type: EXPERIMENTAL
Intervention: Smokers (n=11)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Non-smokers (n=24)
Number of subjects: 35
Study: 12428233

Group type: EXPERIMENTAL
Intervention: DHEA (200 mg/day)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 10323446

Group type: EXPERIMENTAL
Intervention: Cigarette smoking duration > or = 25 cigarettes/day for more than 20 years
Number of subjects: 377481

Group type: EXPERIMENTAL
Intervention: Cigarette smoking intensity (number of cigarettes/day)
Number of subjects: 377481
Study: 8935809

Group type: EXPERIMENTAL
Intervention: 40 mg ziprasidone
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 1913698

Group type: EXPERIMENTAL
Intervention: Sinemet CR (50-200) controlled-release tablets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard Sinemet (25-100) immediate-release tablets
Number of subjects: 0
Study: 6409316

Group type: EXPERIMENTAL
Intervention: Combined measles, mumps, and rubella vaccine (two different batches)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Routine vaccination in schoolchildren aged 12
Number of subjects: 150
Study: 30756250

Group type: EXPERIMENTAL
Intervention: Multi-sensory training (MST)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Wrist stabilization training (WT)
Number of subjects: 98
Study: 31478780

Group type: EXPERIMENTAL
Intervention: AUDIT scores in 2018
Number of subjects: 6

Group type: COMPARATOR
Intervention: AUDIT scores in 2014
Number of subjects: 6
Study: 27575014

Group type: EXPERIMENTAL
Intervention: Dual task walking (hearing a sound, turning head to watch a number, verbalizing it)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Dual task walking
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Subjects affected by cerebral palsy and stroke
Number of subjects: 85
Study: 26817809

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training at 30% of maximal inspiratory pressure for 15 minutes twice a day, 7 days a week, for 12 weeks alongside standard medical treatment.
Number of subjects: 38

Group type: COMPARATOR
Intervention: Standard medical treatment only (control group).
Number of subjects: 38
Study: 24837137

Group type: EXPERIMENTAL
Intervention: Docetaxel (60 mg/m²) with zoledronic acid (group DZ)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Docetaxel (60 mg/m²) without zoledronic acid (group D)
Number of subjects: 100
Study: 22011899

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Amitriptyline and CBT
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo and CBT
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo only
Number of subjects: 47
Study: 19185957

Group type: EXPERIMENTAL
Intervention: alpha-lactalbumin breakfast
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: gelatin + TRP breakfast
Number of subjects: 24

Group type: COMPARATOR
Intervention: casein, soy, or whey-GMP breakfast
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: alpha-lactalbumin or gelatin (+TRP) breakfast
Number of subjects: 24
Study: 17257533

Group type: EXPERIMENTAL
Intervention: NSAID (celecoxib)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 15748470

Group type: EXPERIMENTAL
Intervention: Sodium selenite + vitamin E (A group)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Sodium selenite only (B group)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study: 11437770

Group type: EXPERIMENTAL
Intervention: Anaesthesia with N2O
Number of subjects: 24

Group type: COMPARATOR
Intervention: Anaesthesia without N2O
Number of subjects: 24
Study: 9543976

Group type: EXPERIMENTAL
Intervention: hyper-oxygenated fatty acid esters solution
Number of subjects: 28